Needham raised the firm's price target on Axon to $750 from $600 and keeps a Buy rating on the shares. The firm notes the recent industry checks for Axon, which imply a strong Q2 and Q3 of bookings for the company. Among the key highlights of its findings include the LAPD expansion which more than doubles than annual spend to $22mm with Axon, and the strength in Dedrone opportunities around the World Cup, the analyst tells investors in a research note.